Patient preference and contraindications in measuring quality of care: What do administrative data miss?

Journal of Clinical Oncology

Volumn 31, Issue 21, 2013, Pages 2716-2723

  Ryoo, Joan J ^a,b,c   Ordin, Diana L ^a,f   Antonio, Anna Liza M ^a,d   Oishi, Sabine M ^a   Gould, Michael K ^e   Asch, Steven M ^f,g   Malin, Jennifer L ^a,h  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e KAISER PERMANENTE   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h Wellpoint Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BLACK PERSON; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER SURGERY; CANCER THERAPY; FEMALE; HEALTH CARE QUALITY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PATIENT COMPLIANCE; PATIENT PREFERENCE; PRIORITY JOURNAL; SMALL CELL LUNG CANCER; TREATMENT CONTRAINDICATION; TREATMENT REFUSAL; VERY ELDERLY; INFORMATION PROCESSING; LUNG NEOPLASMS; PSYCHOLOGY; TOTAL QUALITY MANAGEMENT;

AGED; AGED, 80 AND OVER; DATA COLLECTION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PATIENT PREFERENCE; QUALITY IMPROVEMENT; QUALITY INDICATORS, HEALTH CARE;

EID: 84893468453     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.45.7473     Document Type: Article

References (58)

1. Institute of Medicine: Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC, National Academies Press, 2001
2. Institute of Medicine: Performance Measurement: Accelerated Improvement. Washington, DC, National Academies Press, 2006
3. National Quality Forum: Measurement Framework: Evaluating Efficiency Across Patient-Focused Episodes of Care. Washington, DC, National Quality Forum, 2009
4. Persell SD, Wright JM, Thompson JA, et al: Assessing the validity of national quality measures for coronary artery disease using an electronic health record. Arch Intern Med 166:2272-2277, 2006
5. Pawlson LG, Scholle SH, Powers A: Comparison of administrative-only versus administrative plus chart review data for reporting HEDIS hybrid measures. Am J Manag Care 13:553-558, 2007
6. Schneider EC, Nadel MR, Zaslavsky AM, et al: Assessment of the scientific soundness of clinical performance measures: A field test of the National Committee for Quality Assurance’s colorectal cancer screening measure. Arch Intern Med 168:876-882, 2008
7. Quach S, Blais C, Quan H: Administrative data have high variation in validity for recording heart failure. Can J Cardiol 26:306-312, 2010
8. Kmetik KS, O’Toole MF, Bossley H, et al: Exceptions to outpatient quality measures for coronary artery disease in electronic health records. Ann Intern Med 154:227-234, 2011
9. Kerr EA, Smith DM, Hogan MM, et al: Comparing clinical automated, medical record, and hybrid data sources for diabetes quality measures. Jt Comm J Qual Improv 28:555-565, 2002
10. Pronovost PJ, Lilford R: A road map for improving the performance of performance measures. Health Aff 30:569-573, 2011
11. Potosky AL, Saxman S, Wallace RB, et al: Population variations in the initial treatment of non-small-cell lung cancer. J Clin Oncol 22:3261-3368, 2004
12. Shugarman LR, Mack K, Sorbero ME, et al: Race and sex differences in the receipt of timely and appropriate lung cancer treatment. Med Care 47: 774-781, 2009
13. Langer CJ, Moughan J, Movsas B, et al: Patterns of care survey (PCS) in lung cancer: How well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature? Lung Cancer 48:93-102, 2005
14. Smith TJ, Penberthy L, Desch CE, et al: Differences in initial treatment patterns and outcomes of lung cancer in the elderly. Lung Cancer 13:235-252, 1995
15. Lathan CS, Neville BA, Earle CC: The effect of race on invasive staging and surgery in non-small-cell lung cancer. J Clin Oncol 24:413-418, 2006
16. Bradley CJ, Dahman B, Given CW: Treatment and survival differences in older Medicare patients with lung cancer as compared with those who are dually eligible for Medicare and Medicaid. J Clin Oncol 26:5067-5073, 2008
17. Hardy D, Xia R, Liu CC, et al: Racial disparities and survival for nonsmall-cell lung cancer in a large cohort of black and white elderly patients. Cancer 115:4807-4818, 2009
18. Greenwald HP, Polissar NL, Borgatta EF, et al: Social factors, treatment, and survival in early-stage non-small cell lung cancer. Am J Public Health 88:1681-1684, 1998
19. Albano JD, Ward E, Jemal A, et al: Cancer mortality in the United States by education level and race. J Natl Cancer Inst 99:1384-1394, 2007
20. Yang R, Cheung MC, Byrne MM, et al: Do racial or socioeconomic disparities exist in lung cancer treatment? Cancer 116:2437-2447, 2010
21. Bach PB, Cramer LD, Warren JL, et al: Racial differences in the treatment of early-stage lung cancer. N Engl J Med 341:1198-1205, 1999
22. Earle CC, Neumann PJ, Gelber RD, et al: Impact of referral patterns on the use of chemotherapy for lung cancer. J Clin Oncol 20:1786-1792, 2002
23. Wisnivesky JP, McGinn T, Henschke C, et al: Ethnic disparities in the treatment of stage I non-small cell lung cancer. Am J Respir Crit Care Med 171:1158-1163, 2005
24. Esnaola NF, Gebregziabher M, Knott K, et al: Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina. Ann Thorac Surg 86: 220-227, 2008
25. Chang ET, Shema SJ, Wakelee HA, et al: Uncovering disparities in survival after non-small-cell lung cancer among Asian/Pacific Islander ethnic populations in California. Cancer Epidemiol Biomarkers Prev 18:2248-2255, 2009
26. Bradley CJ, Dahman B, Given CW: Inadequate access to surgeons: Reason for disparate cancer care? Med Care 47:758-764, 2009
27. Blackstock AW, Herndon JE 2nd, Paskett ED, et al: Outcomes among African-American/Non-African-American patients with advanced non-small-cell lung carcinoma: Report from the Cancer and Leukemia Group B. J Natl Cancer Inst 94:284-290, 2002
28. Berger M, Lund MJ, Brawley OW: Racial disparities in lung cancer. Curr Probl Cancer 31:202-210, 2007
29. Wang S, Wong ML, Hamilton N, et al: Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans. J Clin Oncol 30:1447-1455, 2012
30. McCann J, Artinian V, Duhaime L, et al: Evaluation of the causes for racial disparity in surgical treatment of early stage lung cancer. Chest 128: 3440-3446, 2005
31. Cykert S, Dilworth-Anderson P, Monroe MH, et al: Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA 303:2368-2376, 2010
32. Brook RH: The RAND/UCLA appropriateness method, in McCormick KA, Moore SR, Siegel RA (eds): Clinical Practice Guidelines Development: Methodology Perspectives. Rockville, MD, Agency for Healthcare Research and Quality, 1994
33. Piccirillo JF, Tierney RM, Costas I, et al: Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 291:2441-2447, 2004
34. Keating NL, Landrum MB, Lamont EB, et al: Quality of care for older patients with cancer in the Veterans Health Administration versus the private sector: A cohort study. Ann Intern Med 154:727-736, 2011
35. Landrum MB, Keating NL, Lamont EB, et al: Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration. Cancer 118:3345-3355, 2012
36. Lathan CS, Okechukwu C, Drake BF, et al: Racial differences in the perception of lung cancer: The 2005 Health Information National Trends Survey. Cancer 116:1981-1986, 2010
37. Margolis ML, Christie JD, Silvestri GA, et al: Racial differences pertaining to a belief about lung cancer surgery: Results of a multicenter survey. Ann Intern Med 139:558-563, 2003
38. Gordon HS, Street RL Jr, Sharf BF, et al: Racial differences in trust and lung cancer patients’ perceptions of physician communication. J Clin Oncol 24:904-909, 2006
39. Silvestri G, Pritchard R, Welch HG: Preferences for chemotherapy in patients with advanced non-small cell lung cancer: Descriptive study based on scripted interviews. BMJ 317:771-775, 1998
40. Weeks JC, Cook EF, O’Day SJ, et al: Relationship between cancer patients’ predictions of prognosis and their treatment preferences. JAMA 279: 1709-1714, 1998
41. Weeks JC, Catalano PJ, Cronin A, et al: Patients’ expectations about effects of chemotherapy for advanced cancer. N Engl J Med 367:1616-1625, 2012
42. Martin MY, Pisu M, Oster RA, et al: Racial variation in willingness to trade financial resources for life-prolonging cancer treatment. Cancer 117: 3476-3484, 2011
43. Keating NL, Landrum MB, Lamont EB, et al: End-of-life care for older cancer patients in the Veterans Health Administration versus the private sector. Cancer 116:3732-3739, 2010
44. Temel JS, Greer JA, Admane S, et al: Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: Results of a randomized study of early palliative care. J Clin Oncol 29:2319-2326, 2011
45. Petersen LA, Normand SL, Daley J, et al: Outcome of myocardial infarction in Veterans Health Administration patients as compared with Medicare patients. N Engl J Med 343:1934-1941, 2000
46. Rosenthal GE, Sarrazin MV, Harper DL, et al: Mortality and length of stay in a Veterans Affairs hospital and private sector hospitals serving a common market. J Gen Intern Med 18:601-608, 2003
47. Ashton CM, Souchek J, Petersen NJ, et al: Hospital use and survival among Veterans Affairs beneficiaries. N Engl J Med 349:1637-1646, 2003
48. Kerr EA, Gerzoff RB, Krein SL, et al: Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: The TRIAD study. Ann Intern Med 141:272-281, 2004
49. Asch SM, McGlynn EA, Hogan MM, et al: Comparison of quality of care for patients in the Veterans Health Administration and patients in a national sample. Ann Intern Med 141:938-945, 2004
50. Selim AJ, Berlowitz D, Kazis LE, et al: Comparison of health outcomes for male seniors in the Veterans Health Administration and Medicare Advantage plans. Health Serv Res 45:376-396, 2010
51. Malin JL, Keating NL: The cost-quality trade-off: Need for data quality standards for studies that impact clinical practice and health policy. J Clin Oncol 23:4581-4584, 2005
52. Persell SD, Kaiser D, Dolan NC, et al: Changes in performance after implementation of a multifaceted electronic-health-record-based quality improvement system. Med Care 49:117-125, 2011
53. Centers for Medicare and Medicaid Services, Department of Health and Human Services: Medicare and Medicaid programs; electronic health record incentive program. Final rule. Fed Regist 75:44314-44588, 2010
54. Harris RE, Hebert JR, Wynder EL: Cancer risk in male veterans utilizing the Veterans Administration medical system. Cancer 64:1160-1168, 1989
55. Campling BG, Hwang WT, Zhang J: A population-based study of lung carcinoma in Pennsylvania: Comparison of Veterans Administration and civilian populations. Cancer 104:833-840, 2005
56. McKinney WP, McIntire DD, Carmody TJ, et al: Comparing the smoking behavior of veterans and nonveterans. Public Health Rep 112:212-217, 1997
57. Kizer KW, Demakis JG, Feussner JR: Reinventing VA health care: Systematizing quality improvement and quality innovation. Med Care 38: I7–I16, 2000 (suppl)
58. Miller DR, Kalman D, Ren XS, et al: Health Behaviors of Veterans in the VHA: Tobacco Abuse: 1999 Large Health Survey of VHA Enrollees. Washington, DC, Veterans Health Administration Office of Quality and Performance, Department of Veterans Affairs, 2001